Randomized trial of protease inhibitor-including vs. protease inhibitor-sparing regimens for women who initiate therapy of HIV infection during pregnancy.
Phase of Trial: Phase III
Latest Information Update: 25 Nov 2013
At a glance
- Drugs Nelfinavir (Primary) ; Lamivudine; Nevirapine; Zidovudine
- Indications HIV infections; HIV-1 infections; Pregnancy
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 06 Apr 2012 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
- 08 Feb 2009 Preliminary results were presented at CROI 2009.
- 16 Sep 2008 Checked against NCT00017719.